POST Online Media Lite Edition


Pfizer appoints Albert Bourla to board

Staff Writer |
New York, N.Y., USA - Pfizer, a pharmaceutical corporation, announced the election of Albert Bourla to its board of directors.

Article continues below

Dr. Bourla is currently the Chief Operating Officer of Pfizer.

Prior to assuming the role of COO in 2018, he was the Group President of Pfizer Innovative Health, responsible for the Consumer Healthcare, Inflammation and Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups.

Dr. Bourla joined Pfizer in 1993, and has held a number of senior global positions in several markets across several disciplines, including: Group President, Global Vaccines, Oncology and Consumer Healthcare business; President and General Manager, Established Products; Area President of Europe, Africa, Middle East, Asia and Pacific, Animal Health; and Vice President, Business Development and New Products, Animal Health.

Dr. Bourla is a doctor of Veterinary Medicine and holds a Ph.D. in Biotechnology of Reproduction from the Veterinary School of Aristotle University.


What to read next

Pfizer/Allergan: Brent Saunders president, COO of the combined company
Pfizer appoints James C. Smith as director
Pfizer: Olivier Brandicourt president and GM, Emerging Markets and Established Products